203 related articles for article (PubMed ID: 30216847)
1. Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study.
Simon C; Caballero C; Gregoire V; Thurnher D; Koivunen P; Ceruse P; Spriano G; Nicolai P; Licitra L; Machiels JP; Hamoir M; Andry G; Mehanna H; Hunter KD; Dietz A; René Leemans C
Eur J Cancer; 2018 Nov; 103():69-77. PubMed ID: 30216847
[TBL] [Abstract][Full Text] [Related]
2. Quality Assurance and Improvement in Head and Neck Cancer Surgery: From Clinical Trials to National Healthcare Initiatives.
Simon C; Caballero C
Curr Treat Options Oncol; 2018 May; 19(7):34. PubMed ID: 29797284
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation.
Leemans CR; Tijink BM; Langendijk JA; Andry G; Hamoir M; Lefebvre JL;
Eur J Surg Oncol; 2013 Sep; 39(9):1013-8. PubMed ID: 23810332
[TBL] [Abstract][Full Text] [Related]
4. The European Organization for Research and Treatment for Cancer (EORTC) strategy for quality assurance in surgical clinical research: Assessment of the past and moving towards the future.
Tanis E; Caballero C; Collette L; Verleye L; den Dulk M; Lacombe D; Schuhmacher C; Werutsky G
Eur J Surg Oncol; 2016 Aug; 42(8):1115-22. PubMed ID: 27241924
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC).
;
Eur J Cancer; 2017 Nov; 86():91-100. PubMed ID: 28964907
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance in head and neck cancer surgery: where are we, and where are we going?
Simon C; Dietz A; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):151-156. PubMed ID: 30664051
[TBL] [Abstract][Full Text] [Related]
7. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
Cardenas CE; Mohamed ASR; Tao R; Wong AJR; Awan MJ; Kuruvila S; Aristophanous M; Gunn GB; Phan J; Beadle BM; Frank SJ; Garden AS; Morrison WH; Fuller CD; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):532-540. PubMed ID: 28258898
[TBL] [Abstract][Full Text] [Related]
8. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.
Ferris RL; Flamand Y; Holsinger FC; Weinstein GS; Quon H; Mehra R; Garcia JJ; Hinni ML; Gross ND; Sturgis EM; Duvvuri U; Méndez E; Ridge JA; Magnuson JS; Higgins KA; Patel MR; Smith RB; Karakla DW; Kupferman ME; Malone JP; Judson BL; Richmon J; Boyle JO; Bayon R; O'Malley BW; Ozer E; Thomas GR; Koch WM; Bell RB; Saba NF; Li S; Sigurdson ER; Burtness B
Oral Oncol; 2020 Nov; 110():104797. PubMed ID: 32679405
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in medical oncology within the EORTC. European Organisation for Research and Treatment of Cancer.
Therasse P; De Mulder PH
Eur J Cancer; 2002 Mar; 38 Suppl 4():S152-4. PubMed ID: 11858984
[TBL] [Abstract][Full Text] [Related]
11. Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach.
Fairchild A; Bar-Deroma R; Collette L; Haustermans K; Hurkmans C; Lacombe D; Maingon P; Poortmans P; Tomsej M; Weber DC; Gregoire V
Eur J Cancer; 2012 May; 48(7):1048-54. PubMed ID: 22387181
[TBL] [Abstract][Full Text] [Related]
12. Quality assurance in EORTC clinical trials. European Organisation for Research and Treatment of Cancer.
Marinus A
Eur J Cancer; 2002 Mar; 38 Suppl 4():S159-61. PubMed ID: 11858986
[TBL] [Abstract][Full Text] [Related]
13. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
14. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.
Johansson KA; Nilsson P; Zackrisson B; Ohlson B; Kjellén E; Mercke C; Alvarez-Fonseca M; Billström A; Björk-Eriksson T; Björ O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Löfroth PO; Löfvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand HO; Wiklund F; Wittgren L
Radiother Oncol; 2008 May; 87(2):290-9. PubMed ID: 18206256
[TBL] [Abstract][Full Text] [Related]
15. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
Bekelman JE; Deye JA; Vikram B; Bentzen SM; Bruner D; Curran WJ; Dignam J; Efstathiou JA; FitzGerald TJ; Hurkmans C; Ibbott GS; Lee JJ; Merchant TE; Michalski J; Palta JR; Simon R; Ten Haken RK; Timmerman R; Tunis S; Coleman CN; Purdy J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):782-90. PubMed ID: 22425219
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on window of opportunity trials in head and neck cancer: lessons from the EORTC 90111-24111-NOCI-HNCG study.
Schmitz S; Caballero C; Locati LD
Eur J Cancer; 2018 Nov; 104():219-223. PubMed ID: 30301582
[TBL] [Abstract][Full Text] [Related]
17. [Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup].
Tao Y; Vintonenko N; Garcia R; Marchesi V; Tomsej M; Bardet E; Bourhis J
Bull Cancer; 2014 May; 101(5):481-5. PubMed ID: 24886899
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.
Amarasena I; Herschtal A; D'Costa I; Fua T; Tiong A; Geddes V; Tran P; Liu C; Corry J
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):541-546. PubMed ID: 28581395
[TBL] [Abstract][Full Text] [Related]
19. Quality assurance in radiotherapy.
Kouloulias VE
Eur J Cancer; 2003 Mar; 39(4):415-22. PubMed ID: 12751370
[TBL] [Abstract][Full Text] [Related]
20. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
